![A transcriptomics-guided drug target discovery strategy identifies receptor ligands for lung regeneration | Science Advances A transcriptomics-guided drug target discovery strategy identifies receptor ligands for lung regeneration | Science Advances](https://www.science.org/cms/10.1126/sciadv.abj9949/asset/8295199c-32e4-427f-ab80-5d647ba5ef2a/assets/images/large/sciadv.abj9949-f1.jpg)
A transcriptomics-guided drug target discovery strategy identifies receptor ligands for lung regeneration | Science Advances
![The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet](https://www.thelancet.com/cms/asset/c652217f-870a-4a98-976d-c433af9ee115/gr1.jpg)
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet
![Combined Microscopic and Metabolomic Approach to Characterize the Skeletal Muscle Fiber of the Ts65Dn Mouse, A Model of Down Syndrome | Microscopy and Microanalysis | Cambridge Core Combined Microscopic and Metabolomic Approach to Characterize the Skeletal Muscle Fiber of the Ts65Dn Mouse, A Model of Down Syndrome | Microscopy and Microanalysis | Cambridge Core](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS143192762002437X/resource/name/S143192762002437X_figAb.png?pub-status=live)
Combined Microscopic and Metabolomic Approach to Characterize the Skeletal Muscle Fiber of the Ts65Dn Mouse, A Model of Down Syndrome | Microscopy and Microanalysis | Cambridge Core
![The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference Berlin, Germany—February 20–23, 2019 | Diabetes Technology & Therapeutics The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference Berlin, Germany—February 20–23, 2019 | Diabetes Technology & Therapeutics](https://www.liebertpub.com/cms/10.1089/dia.2019.2525.abstracts/asset/images/medium/inline1.gif)
The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference Berlin, Germany—February 20–23, 2019 | Diabetes Technology & Therapeutics
![HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2 - Yin - 2021 - Cancer Medicine - Wiley Online Library HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2 - Yin - 2021 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d6b13bc6-d4cd-4e1a-b543-fb1d1d857724/cam44078-toc-0001-m.jpg?trick=1669530640673)
HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2 - Yin - 2021 - Cancer Medicine - Wiley Online Library
![ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression | Nature Communications ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-34871-9/MediaObjects/41467_2022_34871_Fig1_HTML.png)